Literature DB >> 29247618

Malaria control in a tribal area of central India using existing tools.

Neeru Singh1, Ashok K Mishra2, Kalyan B Saha3, Praveen K Bharti4, Dinesh S Sisodia5, Gagan S Sonal6, Akshay C Dhariwal7, Ravendra K Sharma8.   

Abstract

Malaria is difficult to control in central India because of geographical terrain, efficient vectors, and perennial transmission of Plasmodium falciparum and socio-cultural practices of ethnic tribes. The objective was to develop a model to prevent and control malaria in hard to reach areas using existing tools. Baigachak (Tribe population 31,900) situated in Dindori district was undertaken for this study. Intervention measures used are indoor residual spray (IRS), long lasting insecticide treated bed nets (LLINs), prompt diagnosis and treatment along with intensive Information, Education and Communication (IEC) involving school children as agent of change. Door to door rapid fever surveys were carried out in the study area from 2009 to 14 and finger prick blood smears were made from all fever cases and examined under microscope. Mosquitoes were assayed for the presence of sporozoites by enzyme-linked immunosorbent assay (ELISA) technique and sibling species by polymerase chain reaction (PCR). There are two highly efficient vectors i.e. Anopheles culicifacies and An. fluviatilis. In monsoon season of 2009, the man hour density for An. culicifacies was 36.2 which declined to 10.9 during monsoon season of 2010-14 (t = 6.52; p < 0.0001). Epidemiological results revealed that malaria positivity was declined from 27% in 2009-3% in 2014 (Trend chi2 = 57.21; p < 0.0001) and P. falciparum declined from 23.6 to 2.4% (Trend chi2 = 48.33; p < 0.0001). Spleen rate was declined from 47% in 2009-5% in 2014 (χ2 for trend = 6.1; p = 0.0135). Baigachak has achieved a remarkable 89% reduction in malaria. This study confirms that the control strategies undertaken in this study are useful and should be extended at multiple sites for further validation.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Central India; Malaria control; Plasmodium falciparum; Tribal malaria

Mesh:

Year:  2017        PMID: 29247618     DOI: 10.1016/j.actatropica.2017.12.018

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  4 in total

1.  Demonstration of indigenous malaria elimination through Track-Test-Treat-Track (T4) strategy in a Malaria Elimination Demonstration Project in Mandla, Madhya Pradesh.

Authors:  Praveen K Bharti; Harsh Rajvanshi; Sekh Nisar; Himanshu Jayswar; Kalyan B Saha; Man Mohan Shukla; Ashok K Mishra; Ravendra K Sharma; Aparup Das; Harpreet Kaur; Suman L Wattal; Altaf A Lal
Journal:  Malar J       Date:  2020-09-17       Impact factor: 2.979

2.  Improvement of Indoor Residual Spraying and Long-Lasting Insecticidal Net services through structured monitoring and supervision as part of the Malaria Elimination Demonstration Project in Mandla, Madhya Pradesh.

Authors:  Ashok K Mishra; Sekh Nisar; Harsh Rajvanshi; Praveen K Bharti; Kalyan B Saha; Man Mohan Shukla; Ravendra K Sharma; Himanshu Jayswar; Aparup Das; Harpreet Kaur; Suman L Wattal; Altaf A Lal
Journal:  Malar J       Date:  2021-02-18       Impact factor: 2.979

3.  A study of malaria vector surveillance as part of the Malaria Elimination Demonstration Project in Mandla, Madhya Pradesh.

Authors:  Ashok K Mishra; Praveen K Bharti; Anup Vishwakarma; Sekh Nisar; Harsh Rajvanshi; Ravendra K Sharma; Kalyan B Saha; Man Mohan Shukla; Himanshu Jayswar; Aparup Das; Harpreet Kaur; Suman L Wattal; Altaf A Lal
Journal:  Malar J       Date:  2020-12-02       Impact factor: 2.979

4.  Socio-economic and household determinants of malaria in adults aged 45 and above: analysis of longitudinal ageing survey in India, 2017-2018.

Authors:  Indumathi Mohan; Naveen Kumar Kodali; Savitha Chellappan; Balasubramani Karuppusamy; Sujit Kumar Behera; Gopalan Natarajan; Praveen Balabaskaran Nina
Journal:  Malar J       Date:  2021-07-07       Impact factor: 2.979

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.